Both in Biotechnology
Neurocrine Biosciences vs Bio-Techne
Over the past year NBIX returned +2.9% and TECH returned +18.6%; their daily moves had a correlation of -0.00.
NBIX +2.9% TECH +18.6%Growth of $1, one year, split-adjusted
| Metric | NBIX | TECH |
|---|---|---|
| Price | $146.09 | $72.68 |
| Market cap | $14.85B | $11.41B |
| Today | −0.01% | +0.02% |
| 1 month | +2.0% | +0.4% |
| 6 months | +9.0% | +32.8% |
| Year to date | +3.0% | +23.6% |
| 1 year | +5.8% | +19.2% |
| Revenue growth (YoY) | +39.5% | +1.3% |
| Gross margin | 97.6% | 65.8% |
| Net margin | 15.1% | 17.0% |
| P/E (TTM) | 21.0× | 62.8× |
| Price / sales | 4.4× | 9.4× |
| Net cash | $389.8M | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 25.9% | 2.2% |
| Short % of float | 6.6% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).